To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

The PARITY Trial

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
January 2022

The PARITY Trial

Vol: 110| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

A Trial Comparing Prophylactic Intravenous Antibiotic Regimens Following Endoprosthetic Reconstruction for Lower Extremity Bone Tumors

JAMA Oncol . 2022 Jan 6;e216628.

Contributing Authors:
Investigators The PARITY

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Six hundred and eleven patients undergoing surgical resection and endoprosthetic reconstruction for lower extremity bone tumors were randomized to receive a one-day regimen (n=312) or five-day regimen (n=299) of post-operative prophylactic intravenous antibiotics. The primary outcome was surgical site infection as classified according to the criteria established by the Centers for Disease Control ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue